SCHEMBL6199027

SCHEMBL6199027

Cc1ccc(-c2onc3ccc(C=O)cc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 1.00
POLB P06746 5/20 1.00
ALDH1A1 P00352 5/20 1.00
MEN1 O00255 4/20 1.00
KMT2A Q03164 4/20 1.00
NPC1 O15118 3/20 1.00
RAB9A P51151 3/20 1.00
MAPT P10636 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
HPGD P15428 1/20 1.00
PTK2B Q14289 1/20 1.00
IP6K1 Q92551 11/20 0.74
IP6K2 Q9UHH9 10/20 0.68
IP6K3 Q96PC2 9/20 0.68
L3MBTL1 Q9Y468 1/20 0.60
HSP90AA1 P07900 1/20 0.54
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30967420 0.85 IP6K1 (1.00) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL4934034 0.85 ALDH1A1 (1.00) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL25352733 0.85 KDM4E (0.73) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL31265142 0.85 KDM4E (0.73) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL14943768 0.82 ALDH1A1 (0.69) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL25990191 0.81 IP6K1 (1.00) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL25353212 0.81 IP6K1 (0.80) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL30967412 0.78 IP6K1 (0.75) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL6012040 0.76 ALDH1A1 (0.73) KDM4EPOLBALDH1A1MEN1KMT2A
SCHEMBL12401807 0.75 ALDH1A1 (0.59) KDM4EPOLBALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed
EP-1208104-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2002-05-29 EP disclosed
WO-2001016136-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed